Speech-Language Pathologists in Findlay, OH Accepting Medicare

41 Speech-Language Pathologists found. Showing 1 - 20

Sarah Distel Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 537 Cranberry E, Findlay, OH 45840 Phone: 219-575-1646

Michelle Ellerbrock Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 300 Hillcrest Ave # 4185, Findlay, OH 45840 Phone: 419-425-8317

Mary C Estlack, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Western Ave, Suite B, Findlay, OH 45840 Phone: 419-422-5526    Fax: 419-422-5562

Glenn C Hoehne, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8580 Township Road 237, Findlay, OH 45840 Phone: 567-525-4460

Jennifer Earl Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2019 Broad Ave, Findlay, OH 45840 Phone: 773-318-3163

Ms. Cynthia Kay Arthur Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 Broad Ave, Findlay, OH 45840 Phone: 419-425-8310

Barbara A Kampf Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Western Ave, Ste B, Findlay, OH 45840 Phone: 419-422-5526

Life-span Neuro-developmental Therapy Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 E Sandusky St, Suite 3, Findlay, OH 45840 Phone: 419-422-6387    Fax: 419-425-7055

Mrs. Elizabeth Hull Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15603 Brookview Trl, Findlay, OH 45840 Phone: 419-348-8404

Kristin R Campbell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1100 Broad Ave, Findlay, OH 45840 Phone: 419-425-8231

Mrs. Constance Marie Mallamaci, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15100 Birchaven Ln, Findlay, OH 45840 Phone: 419-424-3000

Logan R Haines, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Western Ave, Suite B, Findlay, OH 45840 Phone: 419-422-5526    Fax: 419-422-5562

Mrs. Renee Michele Inkrott, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 E Sandusky St, Findlay, OH 45840 Phone: 419-422-8173    Fax: 419-425-7055

Miss Ashleigh Lynne Kramer, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 600 Jacobs Ave, Findlay, OH 45840 Phone: 419-425-8231

Casey Brandon Casto, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Western Ave, Suite B, Findlay, OH 45840 Phone: 419-422-5526    Fax: 419-422-5562

Carolyn Theresa Charnesky Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1725 Western Ave, Suite B, Findlay, OH 45840 Phone: 419-422-5526    Fax: 419-422-5562

Hayley Carr, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 133 Lexington Ave, Findlay, OH 45840 Phone: 440-537-7019

Brianna L Wicker Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1725 Western Ave Ste B, Findlay, OH 45840 Phone: 419-422-5526

Mrs. Michelle Mccormick Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7746 County Road 140, Findlay, OH 45840 Phone: 419-422-7525

Mrs. Jennifer Welte, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12179 Township Road 109, Findlay, OH 45840 Phone: 419-299-9931

News Archive

Janssen submits canagliflozin NDA with FDA for treatment of type 2 diabetes

Janssen Research & Development, LLC (Janssen), announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the use of canagliflozin, an investigational, oral, once-daily, selective sodium glucose co-transporter 2 (SGLT2) inhibitor, for the treatment of adult patients with type 2 diabetes.

Ortho Clinical Diagnostics' ORTHO VISION Max blood analyzer receives CE Mark clearance

Ortho Clinical Diagnostics today announced ORTHO VISION™ Max, a fully automated blood analyser for high-volume transfusion medicine laboratories, received CE Mark clearance, signifying its conformity with all EU regulation. It will be available for purchase in Europe and Japan in October.

UTILITY receives FDA approval for Investigational New Drug applications

UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.

University of Texas scientist creates promising HIV vaccine candidate

The Abzyme Research Foundation announces today that Dr. Sudhir Paul, a scientist at University of Texas Houston Medical School, has identified an important immunological deficiency in HIV-infected patients and has created a promising HIV vaccine candidate that rectifies the deficiency. The discoveries were presented on July 19th and 20th, 2010 at the XVII International AIDS Society Conference in Vienna, Austria.

Read more Medical News

› Verified 1 days ago

• 1(current)
• 2
• 3